# Canadian Left Atrial Appendage Closure Study

> **NCT03133806** · NA · UNKNOWN · sponsor: **Cardia Inc.** · enrollment: 30 (estimated)

## Conditions studied

- Left Atrial Appendage
- Non-Valvular Atrial Fibrillation

## Interventions

- **DEVICE:** Ultrasept LAA Closure System

## Key facts

- **NCT ID:** NCT03133806
- **Lead sponsor:** Cardia Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02-15
- **Primary completion:** 2018-08
- **Final completion:** 2018-08-15
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03133806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03133806, "Canadian Left Atrial Appendage Closure Study". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03133806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*